Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Tectonic Therapeutic
This study will enroll approximately 191 participants and eligible patients will be randomized to one of 3 treatment arms: * Arm 1: Treatment Group 1: Placebo delivered subcutaneously (SC) every 2 weeks (Q2W) for 24 weeks * Arm 2: Treatment Group 2: TX000045 SC at Dose A Q2W for 24 weeks * Arm 3: Treatment Group 3: TX000045 SC at Dose B Q2W alternating with Placebo Q2W for 24 weeks
Age
18–83
Sex
ALL
Healthy volunteers
Not accepted